Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Healthequity (HQY) EBIAT (2016 - 2026)

Healthequity has reported EBIAT over the past 14 years, most recently at $49.7 million for Q1 2026.

  • Quarterly results put EBIAT at $49.7 million for Q1 2026, up 88.66% from a year ago — trailing twelve months through Jan 2026 was $215.2 million (up 122.54% YoY), and the annual figure for FY2026 was $215.2 million, up 122.54%.
  • EBIAT for Q1 2026 was $49.7 million at Healthequity, down from $51.7 million in the prior quarter.
  • Over the last five years, EBIAT for HQY hit a ceiling of $59.9 million in Q3 2025 and a floor of -$32.8 million in Q1 2022.
  • Median EBIAT over the past 5 years was $14.7 million (2023), compared with a mean of $18.2 million.
  • Biggest five-year swings in EBIAT: plummeted 711.48% in 2022 and later surged 12714.35% in 2024.
  • Healthequity's EBIAT stood at -$1.6 million in 2022, then soared by 994.15% to $14.7 million in 2023, then tumbled by 61.13% to $5.7 million in 2024, then skyrocketed by 806.4% to $51.7 million in 2025, then fell by 3.78% to $49.7 million in 2026.
  • The last three reported values for EBIAT were $49.7 million (Q1 2026), $51.7 million (Q4 2025), and $59.9 million (Q3 2025) per Business Quant data.